$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
Quetiapine Fumarate Market Witness an Outstanding Growth and Strong Revenue by 2027 | AstraZeneca, Intas, TAPI, Accord
02:22pm, Wednesday, 24'th Nov 2021 OpenPR
The global Quetiapine Fumarate market was valued at 168.3 Million USD in 2020 and will grow with a CAGR of 2.24% from 2021 to 2027. ""Quetiapine Fumarate Market"" report offers point by point profiles of the central members to draw
AstraZeneca vaccine may give longer-lasting immunity that is shielding UK from European wave
02:05pm, Wednesday, 24'th Nov 2021 Daily Mail Online
Just 67million doses of AZ have been distributed across the continent compared to 440m doses of the Pfizer-BioNTech jab, even though more recent studies suggest the jab provides longer protection.
Rosenberg Matthew Hamilton Increases Holdings in AstraZeneca PLC (NASDAQ:AZN)
01:34pm, Wednesday, 24'th Nov 2021 Dakota Financial News
Rosenberg Matthew Hamilton lifted its position in AstraZeneca PLC (NASDAQ:AZN) by 33.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 777 shares of the companys stock after purchasing an additional 195 shares during the quarter. Rosenberg Matthew Hamiltons holdings in AstraZeneca []
AstraZeneca Most Effective in Protecting Older People: Firms CEO
11:06am, Wednesday, 24'th Nov 2021 Sada ElBalad English
Leading drug-making company AstraZenecas CEO Pascal Soriot said that the corporations vaccine can provide longer protection, and effectiveness for older people against COVID-19 more than other mRNA-technology-based vaccines such as Pfizer, and Moderna, Politico reported on Tuesday. Hence, the UK hasnt suffered from a high surge in infections, and hospitalizations such as the other European []
Man obsessed by Covid-19 jailed for sparking bomb scare at vaccine plant
11:00am, Wednesday, 24'th Nov 2021 Basingstoke Gazette
Production of the Oxford/AstraZeneca jab at premises in Wrexham ground to a halt in January, causing mayhem.
Cladribine and Pentostatin are anticancer drugs usually used to treat hairy cell leukemia. There is currently no curative treatment for the hairy cell leukemia variant. The results of treatment with cladribine or pentostatin are rather poor. An analysis of 19
Global Ovarian cancer drug report deals with the new business challenges and investment research on the market which includes market attributes, industry structure, and competitive scenario, the problems, desire concepts, together with business strategies and market effectiveness. This is the
Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners
07:25am, Wednesday, 24'th Nov 2021
Needless to say, 2021 has been a banner year for equities, with the S&P 500 up a stunning 25%.
Hutchmed, AstraZeneca launch Phase III Orpathys + Tagrisso combo study in China in lung cancer
06:41am, Wednesday, 24'th Nov 2021 Seeking AlphaItalians to get boosters five months after second shot
06:04am, Wednesday, 24'th Nov 2021 EURACTIV
The minimum period to get a booster shot after taking two doses of the Pfizer/BioNTech, Moderna or AstraZeneca vaccine, or the Johnson & Johnson single-dose, will be five months instead of six, according to a letter published Tuesday by the
Glucagon Like Peptide-1 (GLP-1) Agonists Market 2021 Analysis by Top Manufacturers| Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi, Bristol-Myers Squibb, Amylin
05:25am, Wednesday, 24'th Nov 2021 OpenPR
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2027 Glucagon Like Peptide-1 (GLP-1) Agonists Market research performs thorough market analysis and uses a variety of sources to provide key players with wide-ranging knowledge about industry strategies. This analysis
HUTCHMED, AstraZeneca Initiate Phase III Trial Of ORPATHYS& TAGRISSO In Certain Lung Cancer Patients
03:04am, Wednesday, 24'th Nov 2021 Business Insider Markets
(RTTNews) - HUTCHMED (China) Limited (?HCM) and AstraZeneca Plc. (AZN, AZN.L) said that they have initiated SACHI, a China Phase III study of ORPATHYS (savolitinib), an oral, potent, and highly selective MET tyrosine kinase inhibitor or "TKI", in combination with AstraZeneca''s third-generation, irreversible epidermal growth factor receptor or
AstraZeneca maker suggests its the secret to avoiding Europes fourth wave
12:55am, Wednesday, 24'th Nov 2021 WA Today
The durability of T-cells from the Oxford University jab could be keeping older people safer than those on the European continent.
HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
12:00am, Wednesday, 24'th Nov 2021 Intrado Digital Media
Follows important findings from the TATTON 1 study of the combination in EGFR inhibitor refractory lung cancer patients whose tumors harbor aberrations of MET
Prince Charles opens new AstraZeneca research center
07:30pm, Tuesday, 23'rd Nov 2021 The Daily Telegraph
Britain''s Prince Charles formally opened a new 1 billion pound ($1.3 billion) AstraZeneca research and development (R&D) facility in Cambridge, eastern England, on Tuesday (November 23), as the company aims to fuel the growth of its drug pipeline.
Sign In
Buy AZN